Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Linezolid
Drug ID BADD_D01295
Description Linezolid is a synthetic antibiotic which is used for the treatment of infections caused by aerobic Gram-positive bacteria. Its effects are bacteriostatic against both enterococci and staphylococci and bactericidal against most isolates of streptococci.[L32965] Linezolid exerts its antibacterial activity by inhibiting the initiation of bacterial protein synthesis - more specifically, it binds to the 23S ribosomal RNA of the 50S subunit[A11227,A199050] and, in doing so, prevents the formation of the 70S initiation complex which is essential for bacterial reproduction. Linezolid was initially approved in 2000 and was the first member of the oxazolidinone antibiotic class.[A233425] A second member of this class, [tedizolid], was approved by the FDA in 2014 and is considered generally more effective and tolerable than its predecessor.
Indications and Usage For the treatment of bacterial infections caused by susceptible strains of vancomycin resistant Enterococcus faecium, Staphylococcal aureus (methicillin resistant and susceptible strains), Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae.
Marketing Status Prescription; Discontinued
ATC Code J01XX08
DrugBank ID DB00601
KEGG ID D00947
MeSH ID D000069349
PubChem ID 441401
TTD Drug ID D07UYO
NDC Product Code 62332-183; 66794-219; 0904-6553; 0009-5137; 59762-1308; 68382-413; 67457-324; 66499-0047; 63323-713; 55111-947; 46708-936; 0781-3431; 0409-4883; 0009-5140; 63629-8576; 73377-115; 65841-166; 60687-309; 57664-683; 66022-0103; 70518-1226; 68578-0009; 66022-0201; 31722-749; 59762-1307; 73309-004; 59285-021; 66794-236; 65427-821; 0054-0319; 65162-777; 46708-861; 72606-001; 70771-1111; 40032-022; 46708-183; 62512-0032; 66022-0206; 0009-4992; 58623-0129; 66298-7131; 55150-242; 66298-5137; 0009-5157; 58032-2009; 67457-843; 66039-825; 66298-5140; 57664-682; 66298-7807; 52562-019; 67877-419; 0009-5138; 0781-3433; 0009-7807; 68724-5135; 25021-169; 0009-5136
Synonyms Linezolid | N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide | Linezolide | Zyvox | U 100766 | 100766, U | PNU-100766 | PNU 100766 | PNU100766 | U-100766 | U100766
Chemical Information
Molecular Formula C16H20FN3O4
CAS Registry Number 165800-03-3
SMILES CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Pruritus23.03.12.001--
Pseudomembranous colitis11.02.02.002; 07.19.01.0030.007547%Not Available
Pulmonary alveolar haemorrhage24.07.01.015; 22.01.02.0050.001969%Not Available
Pulmonary embolism24.01.06.001; 22.06.02.001--Not Available
Pyrexia08.05.02.003--
Rash23.03.13.001--Not Available
Rash erythematous23.03.06.0030.015094%Not Available
Rash generalised23.03.13.0020.015094%Not Available
Rash macular23.03.13.0030.007547%Not Available
Red blood cell count decreased13.01.05.0070.011320%Not Available
Red man syndrome23.03.06.011; 10.01.01.013--Not Available
Renal failure20.01.03.0050.016734%Not Available
Respiratory distress22.02.01.0120.011320%Not Available
Respiratory failure22.02.06.002; 14.01.04.0030.014765%
Restlessness17.02.05.021; 19.11.02.0020.011320%
Reticulocyte count decreased13.01.05.0090.011320%Not Available
Rhabdomyolysis15.05.05.0020.060374%
Seizure17.12.03.001--
Sepsis11.01.11.0030.019687%
Septic shock24.06.02.011; 11.01.11.0040.009844%Not Available
Serotonin syndrome17.05.02.004; 15.05.04.016; 12.03.01.0410.158483%Not Available
Serum ferritin increased13.11.01.0260.007547%Not Available
Shock24.06.02.0020.030187%Not Available
Sideroblastic anaemia01.03.02.0090.015094%Not Available
Skin disorder23.03.03.007--Not Available
Skin infection23.09.04.002; 11.01.12.0030.007547%
Skin ulcer24.04.03.007; 23.07.03.003--
Sleep disorder19.02.04.001--Not Available
Somnolence17.02.04.006; 19.02.05.003--
Stevens-Johnson syndrome23.03.01.007; 12.03.01.014; 11.07.01.005; 10.01.03.020--
The 9th Page    First    Pre   9 10 11 12 13    Next   Last    Total 13 Pages